Enplas (6961) Q1 2025 earnings summary

Executive summary

• First-quarter sales rose 9.1% year-over-year to 10,601 million yen, with operating income up 52.5% to 2,153 million yen and profit attributable to owners of parent up 106.3% to 1,518 million yen.

• Growth in Life Science, Digital Communication, and Energy Saving Solution segments offset continued weakness in the Semiconductor segment.

• Comprehensive income increased to 2,880 million yen, with 2,835 million yen attributable to owners of parent.

Financial highlights

• Sales: 10,601 million yen (+9.1% YoY); Operating income: 2,153 million yen (+52.5% YoY); Ordinary income: 2,334 million yen (+38.8% YoY); Profit attributable to owners of parent: 1,518 million yen (+106.3% YoY).

• Gross profit increased to 5,206 million yen from 4,544 million yen YoY.

• Earnings per share increased to 172.00 yen from 83.42 yen YoY.

• COGS ratio improved to 50.9% from 53.2% YoY.

• SGA expenses decreased by 79 million yen YoY.

• Total assets rose to 62,088 million yen as of June 30, 2024, up from 60,028 million yen at the previous fiscal year-end.

• Equity ratio improved to 87.6% from 86.3% sequentially.

Outlook and guidance

• Upward revision for first-half forecast: Net sales now expected at 20,000 million yen, operating income at 3,100 million yen, and profit attributable to owners of parent at 2,200 million yen.

• Full-year net sales forecast at 41,500 million yen (+9.8% YoY), operating profit at 6,600 million yen (+42.1% YoY), and profit attributable to owners of parent at 4,800 million yen (+39.4% YoY).

• Earnings per share for the full year forecasted at 543.69 yen.

• Dividend per share planned at 30.00 yen for first half and 60.00 yen for full year.

• Full-year forecast unchanged except for first-half upward revision; planned FX rate remains at 145.00 yen/USD.

• Semiconductor sales expected to bottom out in 2Q and recover in the second half; Life Science sales to exceed prior year due to new product launches.